Hologic highlights diagnostics portfolio, health care peers set the tone for the stock

By Julia Schmitt, Sector & Peer Group desk. Reviewed prior to publication on 2026-06-28, 11:22.

Hologic (US4364401012) stands out in the U.S. health care sector with its focus on women’s health diagnostics and surgical products. The stock is part of the medical devices peer group, alongside companies such as Abbott Laboratories and Boston Scientific, which anchor investor comparisons on the NASDAQ.

Diagnostics player in a broad health care field

Hologic is best known for its breast and skeletal health, diagnostic, and gynecologic surgical solutions, positioning it firmly in the medical technology segment tied to hospitals and screening programs worldwide.The Hologic company site outlines its portfolio Hologic competes with larger diversified peers like Abbott and Becton Dickinson in diagnostics, while imaging rivals include GE HealthCare and Siemens Healthineers in key equipment categories.GE HealthCare’s news room provides sector context

Health care sector and index backdrop

Hologic shares trade on the NASDAQ in the U.S., where the health care cohort is a significant component of broad indices such as the S&P 500 and sector-focused funds tracking medical technology and services.NASDAQ data show Hologic quoted under ticker HOLX In this group, names like Abbott, Medtronic and Boston Scientific provide reference points for valuation metrics including price-to-earnings ratios and revenue growth within the medtech landscape.A Reuters note on Abbott’s earnings illustrates sector trends

The product behind the stock

Hologic generates revenue from a portfolio centered on breast cancer screening and diagnostics, notably with its 3D mammography systems marketed under the Selenia Dimensions brand, as well as related biopsy devices and imaging software used in hospital and outpatient clinic settings.The Selenia Dimensions mammography system is detailed on Hologic’s product pages

Where the stock trades today

The Hologic shares (US4364401012) trade on NASDAQ under the ticker HOLX; the most recently verifiable quote centers around 76.01 US dollars, based on public price data as of a recent session in June 2026.

Disclaimer: This text is for informational purposes only and does not constitute investment advice, tax advice or a recommendation to buy or sell securities. All data are based on publicly available sources believed to be reliable; accuracy and completeness cannot be guaranteed. Investors should conduct their own research or consult a professional advisor before making investment decisions.